Samarth Kulkarni
Overview
Samarth Kulkarni received an average of $10M in total compensation, including $519K in salary, at CRISPR Therapeutics AG from 2016 to 2021.
2021CRISPR Therapeutics AGChief Executive Officer
2020CRISPR Therapeutics AGChief Executive Officer
2019CRISPR Therapeutics AGChief Executive Officer
2018CRISPR Therapeutics AGChief Executive Officer
2017CRISPR Therapeutics AGChief Executive Officer
2016CRISPR Therapeutics AGChief Executive Officer
Source: SEC filings on April 25, 2022, April 28, 2021, April 24, 2020, and April 30, 2019.
Related executives
We found eight more executives who work or worked at CRISPR Therapeutics AG.
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
James Kasinger
CRISPR Therapeutics AG
General Counsel
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Rodger Novak
CRISPR Therapeutics AG
President
Marc Becker
CRISPR Therapeutics AG
Chief Financial Officer
Kala Subramanian
CRISPR Therapeutics AG
Senior Vice President, Strategic Development and Operations
News
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2021 pay jumps 87% to $17M
April 25, 2022
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2020 pay falls 44% to $9.1M
April 28, 2021
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2019 pay jumps 67% to $16M
April 24, 2020
CRISPR Therapeutics AG CEO Samarth Kulkarni's 2018 pay jumps 40% to $9.7M
April 30, 2019